Skip to main content
Equibles
JANX $16.94 +0.03%
JANX logo
JANX · Janux Therapeutics, Inc.
Track JANX — free

Use JANX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research JANX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$16.94 +0.01 (+0.03%)
Russell 2000 member Rebalance outlook locked
Market Cap
$1.04B
Shares
61.14M
Volume · Oct 22 19.67K Avg daily vol (3M) 844.04K
All webcasts

Earnings call · FY2022 Q3

Janux Therapeutics, Inc. (JANX) Q3 2022 Earnings Call

Concluded Nov 10, 2022
Nov 10, 2022 0 turns
Period
FY2022 Q3
Runtime
—
Sources
2 artifacts
Revenue $1.81M +56.4% YoY
Diluted EPS -$0.40
Net income -$16.70M
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Nov 10, 2022 10-Q report Filed Nov 10, 2022
Full-screen source Call document

JANX alerts

Janux Therapeutics, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →